Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients

NCT04371406 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Regulatory approvals have not been obtained

Conditions

Covid-19

Interventions

DRUG: Hydroxychloroquine and Azithromycin
DIETARY_SUPPLEMENT: Azinc

Sponsor

Assistance Publique - Hôpitaux de Paris